| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.02B | -10.5% |
| Cost of Revenue | $1.09B | -26.0% |
| Gross Profit | $795.2M | +1.7% |
| R&D Expense | $187.6M | +23.6% |
| SG&A Expense | $205.3M | +34.5% |
| Operating Income | $24.3M | -84.0% |
| Interest Expense | $2.0M | -10.8% |
| Pre-tax Income | $42.1M | -72.7% |
| Income Tax | $31.2M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $348.2M | -32.5% |
| Short-term Investments | $25.1M | -50.1% |
| Accounts Receivable | $708.9M | +21.8% |
| Current Assets | $1.26B | -0.3% |
| Total Assets | $2.35B | +18.4% |
| Current Liabilities | $1.08B | +60.6% |
| Total Liabilities | $1.27B | +61.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $256.0M | +15.9% |
| Investing Cash Flow | -$166.1M | -117.5% |
| Financing Cash Flow | -$113.0M | -41.1% |
| +92.9% |
| Net Income | $9.0M | -93.3% |
| EPS (Basic) | $0.15 | -93.2% |
| EPS (Diluted) | $0.14 | -93.3% |
| Stockholders' Equity |
| $1.05B |
| -9.9% |